Fiduciary Trust’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $828K | Sell |
2,140
-89
| -4% | -$33K | 0.01% | 460 |
|
|
2026
Q1 | $653K | Sell |
2,229
-66
| -3% | -$21.7K | 0.01% | 509 |
|
|
2025
Q4 | $804K | Sell |
2,295
-126
| -5% | -$42.6K | 0.01% | 462 |
|
|
2025
Q3 | $782K | Buy |
2,421
+63
| +3% | +$19.6K | 0.01% | 468 |
|
|
2025
Q2 | $917K | Buy |
2,358
+262
| +13% | +$105K | 0.01% | 416 |
|
|
2025
Q1 | $912K | Sell |
2,096
-25
| -1% | -$10K | 0.01% | 404 |
|
|
2024
Q4 | $782K | Sell |
2,121
-534
| -20% | -$223K | 0.01% | 404 |
|
|
2024
Q3 | $1.38M | Buy |
2,655
+586
| +28% | +$313K | 0.02% | 310 |
|
|
2024
Q2 | $1.12M | Buy |
2,069
+3
| +0.1% | +$1.59K | 0.02% | 323 |
|
|
2024
Q1 | $1.07M | Buy |
2,066
+7
| +0.3% | +$3.48K | 0.02% | 337 |
|
|
2023
Q4 | $971K | Buy |
2,059
+190
| +10% | +$87.9K | 0.02% | 342 |
|
|
2023
Q3 | $814K | Sell |
1,869
-164
| -8% | -$74.4K | 0.01% | 346 |
|
|
2023
Q2 | $903K | Sell |
2,033
-51
| -2% | -$23.5K | 0.02% | 347 |
|
|
2023
Q1 | $958K | Buy |
2,084
+84
| +4% | +$40K | 0.02% | 335 |
|
|
2022
Q4 | $1.03M | Buy |
2,000
+151
| +8% | +$76.7K | 0.02% | 334 |
|
|
2022
Q3 | $840K | Buy |
1,849
+17
| +0.9% | +$8.13K | 0.02% | 349 |
|
|
2022
Q2 | $885K | Sell |
1,832
-45
| -2% | -$22.3K | 0.02% | 346 |
|
|
2022
Q1 | $922K | Buy |
1,877
+488
| +35% | +$223K | 0.02% | 360 |
|
|
2021
Q4 | $644K | Sell |
1,389
-2
| -0.1% | -$841 | 0.01% | 430 |
|
|
2021
Q3 | $519K | Sell |
1,391
-13
| -0.9% | -$4.94K | 0.01% | 471 |
|
|
2021
Q2 | $536K | Buy |
1,404
+35
| +3% | +$13.4K | 0.01% | 453 |
|
|
2021
Q1 | $492K | Sell |
1,369
-660
| -33% | -$212K | 0.01% | 454 |
|
|
2020
Q4 | $652K | Sell |
2,029
-255
| -11% | -$78.3K | 0.01% | 385 |
|
|
2020
Q3 | $613K | Buy |
2,284
+500
| +28% | +$135K | 0.01% | 365 |
|
|
2020
Q2 | $469K | Sell |
1,784
-4
| -0.2% | -$1.07K | 0.01% | 391 |
|
|
2020
Q1 | $406K | Sell |
1,788
-1,501
| -46% | -$409K | 0.01% | 374 |
|
|
2019
Q4 | $993K | Buy |
3,289
+1,289
| +64% | +$355K | 0.02% | 280 |
|
|
2019
Q3 | $480K | Buy |
2,000
+82
| +4% | +$22.5K | 0.01% | 379 |
|
|
2019
Q2 | $542K | Buy |
1,918
+225
| +13% | +$61.5K | 0.01% | 346 |
|
|
2019
Q1 | $486K | Hold |
1,693
| – | – | 0.01% | 353 |
|
|
2018
Q4 | $445K | Hold |
1,693
| – | – | 0.01% | 338 |
|
|
2018
Q3 | $464K | Sell |
1,693
-58
| -3% | -$15.1K | 0.01% | 345 |
|
|
2018
Q2 | $416K | Sell |
1,751
-162
| -8% | -$37.5K | 0.01% | 346 |
|
|
2018
Q1 | $420K | Sell |
1,913
-49
| -2% | -$11.5K | 0.01% | 343 |
|
|
2017
Q4 | $441K | Sell |
1,962
-100
| -5% | -$21.3K | 0.01% | 330 |
|
|
2017
Q3 | $391K | Sell |
2,062
-67
| -3% | -$12.8K | 0.01% | 342 |
|
|
2017
Q2 | $400K | Sell |
2,129
-1,596
| -43% | -$287K | 0.01% | 342 |
|
|
2017
Q1 | $616K | Hold |
3,725
| – | – | 0.02% | 307 |
|
|
2016
Q4 | $536K | Sell |
3,725
-377
| -9% | -$50.5K | 0.02% | 321 |
|
|
2016
Q3 | $514K | Sell |
4,102
-2,413
| -37% | -$312K | 0.02% | 327 |
|
|
2016
Q2 | $856K | Sell |
6,515
-94
| -1% | -$12.9K | 0.03% | 279 |
|
|
2016
Q1 | $919K | Buy |
6,609
+416
| +7% | +$55.6K | 0.03% | 268 |
|
|
2015
Q4 | $863K | Buy |
6,193
+2,919
| +89% | +$402K | 0.04% | 248 |
|
|
2015
Q3 | $458K | Buy |
3,274
+1,850
| +130% | +$278K | 0.02% | 287 |
|
|
2015
Q2 | $233K | Hold |
1,424
| – | – | 0.01% | 325 |
|
|
2015
Q1 | $220K | Buy |
+1,424
| New | +$203K | 0.01% | 327 |
|
Other funds holding ELV
Fiduciary Trust's ELV Position: Q2 2026 in Review
Fiduciary Trust reduced its Elevance Health (ELV) stake by 4% in Q2 2026, selling an estimated $33K and leaving 2,140 shares worth $828K. The position accounts for 0.01% of the portfolio, ranked #460.
Fiduciary Trust first reported a position in ELV in Q1 2015 and has held it in 46 quarters since. The position peaked at $1.38M in Q3 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Fiduciary Trust held 2,140 shares of Elevance Health worth $828K as of Q2 2026.
- Fiduciary Trust sold 89 Elevance Health shares in Q2 2026, an estimated $33K.
- Elevance Health made up 0.01% of Fiduciary Trust's portfolio in Q2 2026, its #460 holding.
- Fiduciary Trust first reported a position in Elevance Health in Q1 2015 and has held it in 46 quarters since.
- Fiduciary Trust's Elevance Health position peaked at $1.38M in Q3 2024.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.